In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.
Genetic Technologies Limited Balance Sheet Statement - Assets
As of 30 Jun 2024, The total current assets of Genetic Technologies Limited (ASX:GTG) was around $3,695,375 which consisted of $1,020,608 of Cash, $206,468 of Inventory and $2,126,553 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.
All amounts in AUD
The latest balance sheet of Genetic Technologies Limited also showed $264,491 of Property Plant Equipment and $1,784,893 of Good will. Also there were $360,064 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $6,186,521.
Genetic Technologies Limited Balance Sheet Statement - Liabilities
GTG's latest annual results shows the balance sheet has $1,458,181 of Accounts Payable. Also there were $875,189 of Short/Long term debt, no Long term debt, no Other Current liabilities and $4,195,463 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.
As per the 30 Jun 2024's annual report of Genetic Technologies Limited, the total liabilities were $4,356,106.
GTG Balance Sheet Statement - Stock Holder Equity
Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.
The latest Balance sheet of Genetic Technologies Limited showed the total stock holder equity was $1,830,415 which consisted of $163,817,863 of Common stocks, $-166,376,076 of Retained earnings and no Other stock holder equity.
GTG Balance Sheet Statement History
Following table shows the history of balance sheet for Genetic Technologies Limited (GTG).
| 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | |
|---|---|---|---|---|
| Cash | 1,020,608 | 7,851,197 | 11,731,325 | 20,902,282 |
| Net Receivables | 2,126,553 | 1,921,657 | 2,421,238 | 1,074,325 |
| Inventory | 206,468 | 325,893 | 398,150 | 76,927 |
| Total Current Assets | 3,695,375 | 10,497,795 | 14,716,800 | 22,236,114 |
| Property Plant Equipment | 264,491 | 599,176 | 953,325 | 637,706 |
| Good Will | 1,784,893 | 3,116,893 | 4,506,653 | - |
| Intangible Assets | 360,064 | 520,472 | 624,920 | - |
| Other Assets | - | - | - | - |
| Deferred Long Term Asset Charges | - | - | - | - |
| Total Assets | 6,186,521 | 14,856,237 | 20,801,698 | 22,971,688 |
| Accounts Payable | 1,458,181 | 837,952 | 1,153,856 | 269,665 |
| Short/Long Term Debt | 875,189 | 532,846 | 652,526 | 204,038 |
| Other Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Other Liabilities | - | - | - | - |
| Total Current Liabilities | 4,195,463 | 3,312,045 | 3,811,719 | 1,405,381 |
| Total Liabilities | 4,356,106 | 3,693,661 | 4,370,627 | 1,438,653 |
| Common Stock | 163,817,863 | 161,342,707 | 155,138,636 | 153,574,974 |
| Retained Earnings | -166,376,076 | -156,715,687 | -150,206,216 | -143,075,218 |
| Treasury Stock | - | - | - | - |
| Other Stockholder Equity | - | - | - | - |
| Total Stockholder Equity | 1,830,415 | 11,162,576 | 16,431,071 | 21,533,035 |
| Net Tangible Assets | -314,542 | 7,525,211 | 11,299,498 | 21,533,035 |
Genetic Technologies Limited (ASX:GTG) Balance Sheet Statement FAQ
1. How much Cash Genetic Technologies Limited has on their balance sheet?
As of 30 Jun 2024, Genetic Technologies Limited (ASX:GTG) has $1,020,608 of Cash.
2. What's the long term debt of Genetic Technologies Limited?
As per the latest Balance sheet of Genetic Technologies Limited (ASX:GTG), it has no Long term debt.
3. How much share holder equity does Genetic Technologies Limited has?
The Genetic Technologies Limited (ASX:GTG)'s balance sheet shows that it has $1,830,415 of Total stock holder equity.